Pivya (Pivmecillinam)

Pivmecillinam is an antibiotic used to treat bladder infections (simple urinary tract infections) in adult women. It is taken as a pill. It works by breaking down the outer wall of the bacteria so they die.

Brand names:Selexid, Pivya
Medication

What people taking Pivya (Pivmecillinam) report

Every report comes from a Lived member, sent anonymously.

Have you tried Pivya (Pivmecillinam) for UTI (Urinary Tract Infection)?

NameHow it went

About Pivya (Pivmecillinam)

What It's For

Amdinocillin pivoxil, more often called pivmecillinam, is an antibiotic in the penicillin family taken by mouth. In the United States it is sold as Pivya, approved by the US Food and Drug Administration (FDA) in 2024 to treat uncomplicated urinary tract infections (UTIs) in women 18 and older. An uncomplicated UTI is a bladder infection in someone whose urinary tract is otherwise normal, and the approval covers infections caused by the bacteria that most often cause them, including E. coli. Pivmecillinam is not new. It has been used for more than four decades in Europe, and more recently in Canada, where it is sold under names such as Selexid, and bacteria there have stayed notably slow to develop resistance to it. Outside the US it is also used more broadly, but the US approval does not cover men, children, kidney infections or complicated UTIs, and evidence for kidney infections is limited.

How It Works

Pivmecillinam itself is inactive. It is a prodrug: a form designed to be absorbed well from the gut, which the body then converts into mecillinam, the antibiotic that does the work. Mecillinam is filtered out by the kidneys, so much of it ends up in the urine, where bladder infections occur. Like other penicillins, mecillinam stops bacteria from building their cell walls, so they cannot grow and break apart. It latches onto a different part of that wall-building machinery than most penicillins do, which helps explain why it often still works against bacteria that resist other common UTI antibiotics.

Dosage & Administration

Pivya is a 185 mg tablet taken three times a day, usually for 3 to 7 days depending on what the prescriber judges the infection needs. It can be taken with or without food. European products such as Selexid come in a different strength with their own schedule, so the instructions on the prescription label are the ones to follow. Take the full course even if symptoms ease after a day or two; stopping early makes it more likely the infection returns or that the bacteria become harder to treat. If a dose is missed, take it as soon as you remember, but do not double up to catch up. Swallowing the tablet with a full glass of water helps it go down cleanly, since irritation of the esophagus (the food pipe) has occasionally been reported.

Side Effects

Most people take pivmecillinam without trouble. In clinical trials the most common side effects were nausea and diarrhea, each affecting a few percent of people, followed by vaginal yeast infections, genital itching and headache. These usually settle once the short course ends. Serious reactions are uncommon but matter. Stop taking it and get medical attention right away for a new rash, especially one with blisters, peeling skin or sores in the mouth, since rare severe skin reactions have been reported. Swelling of the face, lips or throat, or trouble breathing, signals a serious allergic reaction and needs emergency care. As with nearly all antibiotics, watery or bloody diarrhea, sometimes with cramps or fever, can be a sign of a C. difficile bowel infection. It can appear during treatment or even two months or more after the last dose, and should be reported to a clinician promptly rather than treated at home with anti-diarrhea medicine.

Interactions & Warnings

Pivmecillinam should not be used by anyone who has had a serious allergic reaction to it or to other beta-lactam antibiotics, the group that includes penicillins such as amoxicillin and cephalosporins such as cephalexin. Tell the prescriber about any past antibiotic allergy, even a mild one. When the body converts pivmecillinam, it releases a substance called pivalate, which leaves the body by binding to carnitine, a nutrient muscles use for energy. A short course is not known to cause problems in most people, but this is why the drug is not used long term, and why it is avoided in people with inherited disorders that already cause carnitine deficiency. People with significant kidney disease or very low muscle mass may be steered toward another antibiotic. It is also best avoided with valproate (valproic acid, sold as Depakote among others), a seizure and mood medicine that drains carnitine too. Low blood sugar, muscle aches, tiredness or confusion are the signs of carnitine depletion to watch for if the two must be combined. Pivmecillinam is not used in people with acute porphyria, a rare inherited blood disorder, because it can set off attacks. It can also slow the clearance of methotrexate, a drug used for some cancers and for rheumatoid arthritis, so the prescriber should know if you take it. Observational studies of tens of thousands of pregnancies exposed in the first trimester have not shown an increased risk of birth defects. Anyone pregnant should tell the prescriber, who can weigh it against other options. Taken shortly before delivery, it can cause a false positive result for a rare metabolic disorder (isovaleric acidemia) on the newborn screening test. A positive result still needs prompt follow-up, and the newborn's care team should be told about the medicine.

What to Expect

Burning, urgency and frequent urination should improve over the course of treatment. In the trials behind the US approval, about 6 in 10 women treated for a week were free of symptoms and had a clear urine culture about a week and a half after starting, compared with 1 in 10 given a placebo. In a separate trial, a 3-day course worked about as well as a week of cephalexin, another commonly used antibiotic. If symptoms are not improving, or fever or pain in the back or side below the ribs develops, contact the prescriber promptly. These can mean the infection is more than a simple bladder infection, and pivmecillinam is not an established treatment for kidney infections. It is often chosen based on the usual bacteria behind bladder infections and local resistance patterns.

Questions to Ask Your Doctor

  1. 1.Why is pivmecillinam a better fit for this infection than nitrofurantoin, trimethoprim-sulfamethoxazole or another common UTI antibiotic?
  2. 2.How many days should I take it, and what should I do if my symptoms are not better by then?
  3. 3.Given my past antibiotic reactions, is it safe for me to take a penicillin-family drug?
  4. 4.Do any of my medicines, such as valproate or methotrexate, or my kidney health, make a different antibiotic safer?
  5. 5.If I get UTIs often, what is the plan for future infections, and will repeated courses be a concern?

Last reviewed • Oct 2026

Educational content, not medical advice.